ATP6AP1 and hepatocellular carcinoma: Subsequently, through a five-year follow-up of 63 clinical patients and using the K-M plotter database, the relationship between relapse-free survival (RFS) analysis and the expression of ATP6AP1, PSMD14 and HSP90AB1 in HCC tissues was determined.